Mimedx (MDXG) Restructuring Costs (2023)
Mimedx's (MDXG) quarterly Restructuring Costs came in at $208000.0 in Q3 2023, down 93.61% quarter-over-quarter from $3.3 million in Q2 2023.
Powered by 
Analysis
Mimedx (MDXG) Restructuring Costs (2023) Analysis & Trends
Mimedx has disclosed Restructuring Costs across 1 years of filings, most recently posting $208000.0 for Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.02 Bn | 176.42 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.91 Bn | 109.10 Bn | 6.34 Bn |
| 4 | Stryker | 105.64 Bn | 102.17 Bn | 4.50 Bn |
| 5 | Boston Scientific | 64.99 Bn | 64.45 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.92 Bn | 45.67 Bn | 1.35 Bn |
| 7 | Alcon | 33.23 Bn | 31.78 Bn | 1.68 Bn |
| 8 | Dexcom | 32.10 Bn | 30.16 Bn | 830.00 Mn |
| 9 | Steris | 20.83 Bn | 20.35 Bn | 684.20 Mn |
| 10 | Mimedx | 684.29 Mn | 548.46 Mn | 44.38 Mn |